Do men make informed decisions about prostate cancer screening? Baseline results from the "take the wheel" trial
- PMID: 20484092
- PMCID: PMC4386607
- DOI: 10.1177/0272989X10369002
Do men make informed decisions about prostate cancer screening? Baseline results from the "take the wheel" trial
Abstract
Background: Baseline data from a randomized trial in 12 worksites were analyzed. Men aged 45+ (n = 812) completed surveys documenting screening history, screening preferences and decisions, CaP knowledge, decision self-efficacy, and decisional consistency. Psychosocial and demographic correlates of IDM were also assessed.
Results: Approximately half of the sample had a prior PSA test, although only 35% reported having made an explicit screening decision. Across the sample, CaP knowledge was low (mean = 56%), although decision self-efficacy was high (mean = 78%), and the majority of men (81%) made decisions consistent with their stated values. Compared with those who were undecided, men who made an explicit screening decision had significantly higher levels of knowledge, greater decisional self-efficacy, and were more consistent in terms of making a decision in alignment with their values. They tended to be white, have high levels of income and education, and had discussed screening with their health care provider.
Conclusions: Many men undergo CaP screening without being fully informed about the decision. These findings support the need for interventions aimed at improving IDM about screening, particularly among men of color, those with lower levels of income and education, and those who have not discussed screening with their provider.
Similar articles
-
Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.J Cancer Educ. 2016 Dec;31(4):693-701. doi: 10.1007/s13187-015-0870-8. J Cancer Educ. 2016. PMID: 26498649 Free PMC article.
-
Preparing African American Men to Make Informed Prostate Cancer Screening Decisions: Development and Pilot Testing of an Interactive Online Decision Aid.JMIR Mhealth Uhealth. 2020 May 5;8(5):e15502. doi: 10.2196/15502. JMIR Mhealth Uhealth. 2020. PMID: 32369032 Free PMC article.
-
Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?J Fam Pract. 1999 Sep;48(9):682-8. J Fam Pract. 1999. PMID: 10498074
-
Decision making and prostate cancer screening.Urol Clin North Am. 2014 May;41(2):257-66. doi: 10.1016/j.ucl.2014.01.008. Epub 2014 Feb 28. Urol Clin North Am. 2014. PMID: 24725488 Review.
-
Decision aids for people facing health treatment or screening decisions.Cochrane Database Syst Rev. 2014 Jan 28;(1):CD001431. doi: 10.1002/14651858.CD001431.pub4. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2017 Apr 12;4:CD001431. doi: 10.1002/14651858.CD001431.pub5. PMID: 24470076 Updated. Review.
Cited by
-
Decision aids for people facing health treatment or screening decisions.Cochrane Database Syst Rev. 2024 Jan 29;1(1):CD001431. doi: 10.1002/14651858.CD001431.pub6. Cochrane Database Syst Rev. 2024. PMID: 38284415 Review.
-
Associations of Content and Context of Communication with Prostate-Specific Antigen Testing.Int J Environ Res Public Health. 2023 May 4;20(9):5721. doi: 10.3390/ijerph20095721. Int J Environ Res Public Health. 2023. PMID: 37174239 Free PMC article.
-
The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trial.PLoS Med. 2020 Feb 7;17(2):e1003033. doi: 10.1371/journal.pmed.1003033. eCollection 2020 Feb. PLoS Med. 2020. PMID: 32032355 Free PMC article. Clinical Trial.
-
African American Women's Involvement in Promoting Informed Decision-Making for Prostate Cancer Screening Among Their Partners/Spouses.Am J Mens Health. 2018 Jul;12(4):884-893. doi: 10.1177/1557988317742257. Epub 2018 Jan 4. Am J Mens Health. 2018. PMID: 29298558 Free PMC article.
-
Decision aids for people facing health treatment or screening decisions.Cochrane Database Syst Rev. 2017 Apr 12;4(4):CD001431. doi: 10.1002/14651858.CD001431.pub5. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2024 Jan 29;1:CD001431. doi: 10.1002/14651858.CD001431.pub6. PMID: 28402085 Free PMC article. Updated. Review.
References
-
- American Cancer Society. Overview: Cervical Cancer: How many women get cancer of the cervix. Washington DC: ACS; 2008.
-
- American Cancer Society. Cancer Facts and Figures for African Americans, 2007–2008. Atlanta, GA: American Cancer Society; 2007.
-
- Andriole GL, Crawford ED, Grubb RL, 3rd, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360(13):1310–1319. - PMC - PubMed
-
- Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Maattanen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360(13):1320–1328. - PubMed
-
- Barry M. Screening for prostate cancer—the controversy the refuses to die. New England Journal of Medicine. 2009;360(13):1351–1353. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
